{"name":"Livongo Health","slug":"livongo","ticker":"LVGO (merged)","exchange":"NASDAQ (merged with Teladoc)","domain":"livongo.com","description":"Teladoc Health, Inc. is a multinational telemedicine and virtual healthcare company founded in 2002. Headquartered in New York City, its services include telehealth, employer-sponsored health plans, 24/7 care, mental health, diabetes and hypertension management, primary care, prescriptions, medical opinions, AI and analytics, telehealth devices and licensable platform services.","hq":"Mountain View, CA","founded":0,"employees":"","ceo":"Jason Gorevic (Teladoc CEO)","sector":"Digital Health","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"Merged (Teladoc ~$2.5B)","metrics":{"revenue":420000000,"revenueGrowth":148.7,"grossMargin":0,"rdSpend":49842000,"netIncome":-55270000,"cash":560561000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2019"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2022-02-22","type":"deal","headline":"Livongo Health to be Acquired by Teladoc Health for $18.5 Billion","summary":"Teladoc Health agreed to acquire Livongo Health in an all-stock deal valued at $18.5 billion.","drugName":"","sentiment":"positive"},{"date":"2021-02-08","type":"earnings","headline":"Livongo Health Reports Fourth Quarter and Full Year 2020 Financial Results","summary":"Livongo Health reported revenue of $143.8 million for the fourth quarter of 2020, up 83% year-over-year.","drugName":"","sentiment":"positive"},{"date":"2020-09-01","type":"regulatory","headline":"Livongo Health Receives FDA Clearance for Its Diabetes Management Platform","summary":"Livongo Health received FDA clearance for its diabetes management platform, which provides personalized coaching and support to individuals with diabetes.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiTkFVX3lxTFBsZlhrX083N2phOHdzSmR4enFLWjhZNXYySVFHSFdkV05Cc1ducEdSVXFxMlZuSGYteTFuUVkzQTFzUTJMeHo4U3JUYmNfZw?oc=5","date":"2020-09-16","type":"pipeline","source":"Stock Titan","summary":"Latest LVGO News - Define Ventures Appoints Carolyn Magill as ... - Stock Titan","headline":"Latest LVGO News - Define Ventures Appoints Carolyn Magill as ...","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2020-08-05","type":"deal","source":"globenewswire.com","summary":"LIVONGO HEALTH, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Merger - globenewswire.com","headline":"LIVONGO HEALTH, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Merger","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPakhsc0gxV2E5WDVCZWlYcnpWS0g3YVA5dG5SalBBWHdUc3RHUmZtdW1mLTBQZmJYenFxcU1XTi0wQ1BuRDAzZndaWWg3c1Y0d1I3c1p5TFFlY3ZETTJ0cGJUeUxLQ2x5M3ZsX1Ryb1JKN3lHRUNCcFNfUGlXQ1R2dnA2VFlmQnBvcV9VNWY2b3l2eXhOR3BJ?oc=5","date":"2020-07-17","type":"deal","source":"InvestorPlace","summary":"7 New Stocks to Buy for 2021 and Beyond That Will Deliver - InvestorPlace","headline":"7 New Stocks to Buy for 2021 and Beyond That Will Deliver","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":3,"keyCompetitors":["Oscar Health","Teladoc Health","1Life Healthcare"],"therapeuticFocus":["Diabetes Management","Behavioral Health"],"financials":{"source":"sec_edgar+yahoo","revenue":170198000,"revenuePeriod":"2019-12-31","revenueHistory":[{"value":170198000,"period":"2019-12-31"},{"value":68431000,"period":"2018-12-31"},{"value":30850000,"period":"2017-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":49842000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-55270000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":560561000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}